OnabotulinumtoxinA (BTX) chemodenervation is an established third-line therapy for overactive bladder. The aim of our study was to further characterize the physiologic effect of various BTX injection distributions on ambulatory and cystometric voiding function in conscious awake rats.
INTRODUCTION AND OBJECTIVES:
OnabotulinumtoxinA (BTX) chemodenervation is an established third-line therapy for overactive bladder. The aim of our study was to further characterize the physiologic effect of various BTX injection distributions on ambulatory and cystometric voiding function in conscious awake rats.
METHODS: Adult female rats (n¼36) were divided into six groups. Treatment animals received injection of 7.5 units BTX (in 25-125 mL saline; 25 mL/aliquot): intact control, saline vehicle control, unilateral BTX, trigone BTX, posterior-lateral BTX, whole bladder BTX. Micturition frequency and volume were assessed using metabolic cages at baseline (day 0, 7) and following injection (day 14, 21, 28) . Bladder function was then assessed using anesthetized acetic acid cystometry.
RESULTS: There was no overall correlation between rat weight and mean voided volume (r ¼ -0.02, p ¼ 0.81). Small volume voids were significantly associated with increased food intake (r ¼ -0.21, p ¼ 0.006) and greater stool output (r ¼ -0.23, p ¼ 0.003). Mean nocturnal voided volume was similar in control, vehicle, trigone and posteriorlateral groups. The ability to void small volumes was preserved in both the control and treatment groups with the exception of unilateral and whole bladder injection which demonstrated increased minimum voided volumes. On cystometry, mean voided volume was the greatest in the control and trigone groups prior to acetic acid. Increased threshold pressure was noted in both unilateral and whole bladder injection groups. Post void residual was decreased in all groups after acetic acid. The lowest number of voids and longest interval between voids was noted after unilateral and whole bladder BTX injection. Cystometric intercontractile interval correlated with increased nocturnal mean voided volume before (r ¼ 0.33, p ¼ 0.05) and after (r ¼ 0.24, p ¼ 0.17) acetic acid. Cystometric mean voided volume correlated with ambulatory nocturnal voided volume, however was almost 10-fold lower after saline instillation (r ¼ 0.18, p ¼ 0.30), and more closely approximated ambulatory voiding after acetic acid instillation (r ¼ 0.30, p ¼ 0.08).
CONCLUSIONS: Unilateral and whole bladder BTX injection resulted in elevated ambulatory nocturnal mean voided volumes, with higher pressure and smaller volume voids noted on cystometry. Trigone and posterior-lateral BTX injection patterns appear to preserve contractility, with threshold and peak contraction pressures similar to control animals. imposes time-dependent changes in bladder physiology. An early increase in mechanical loading due to polyuria followed by the accumulation of oxidative stress products are seen as key factors driving the bladder from a compensated overactive to a decompensated atonic state. In this study we investigated whether chronic mechanical overdistension triggers hypoxic responses in the bladder urothelium and determined if these responses corresponded with the transition from compensated to decompensated state. Hypoxic responses were evaluated by measuring changes in expression levels of the hypoxia inducible factor-1a (HIF-1a) and of the downstream HIF regulated Vascular Endothelial Growth Factor (VEGF).
METHODS: Studies were performed with 10 week old male C57BL/6 mice treated for 1, 4, 12, 36 weeks with 5% sucrose in the drinking water (diuresis mouse model was used to avoid confounding effects of hyperglycemia), and non-treated age-matched control mice. Void Stain on Paper (VSOP) was used to longitudinally quantify changes in voiding frequency (VF). Bladders were harvested at the end of each time point, the urothelium dissected, and processed for quantification of HIF-1a and VEGF mRNA by real-time quantitative PCR (qPCR).
RESULTS: HIF-1a and VEGF mRNA expression were upregulated after 1 week of sucrose-induced diuresis (1wk -HIF-1a: 1.85AE0.08 and VEGF: 1.57AE0.21; mRNA norm. to mean Ctrl value; N ¼ 4, P<0.05), and then progressively decreased (4 wks -HIF-1a: 1. 20AE0.07 and VEGF 0.80AE0.09; N¼ 4; P<0.05; VEGF: 0.97AE0.11; N ¼ 4) to reach values that were significantly lower or equivalent to controls by 36 weeks (HIF-1a: 0.87AE0.05, P<0.05; VEGF: 1.05AE0.06; N ¼ 4). Upregulation of HIF-1a and VEGF coincided with emergence of detrusor overactivity (1 wk VF: Ctrl 0.51AE0.09 vs Suc-fed 0.95AE0.18, N ¼ 6-9, P<0.05) whereas downregulation was seen in conjunction with bladder underactivity (36 wks VF: Ctrl: 0.40AE0.08 vs Suc-fed: 0.51AE0.12, N¼6-9). CONCLUSIONS: Chronic bladder over-distension triggers timedependent changes in HIF-1a and VEGF expression in the bladder urothelium. The early upregulation of HIF-1a and VEGF expression suggests that hypoxic responses may contribute to emergence of detrusor overactivity. In contrast, HIF-1a and VEGF downregulation observed as the bladder transitions to a decompensated state, suggests that factors other than those driven by hypoxia are likely involved in this response.
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